Severe breakthrough COVID-19 cases in the SARS-CoV-2 delta (B.1.617.2) variant era

Lancet Microbe. 2022 Jan;3(1):e4-e5. doi: 10.1016/S2666-5247(21)00306-2. Epub 2021 Dec 3.

Authors

Stephen Y Wang¹, Prerak V Juthani², Kelly A Borges³, Marcus K Shallow¹, Akash Gupta¹, Christina Price¹, Christine H Won^{1

4}, Hyung J Chun^{5

1

4}

Affiliations

¹ Department of Internal Medicine, New Haven, CT 06511, USA.
² Yale School of Medicine, New Haven, CT 06511, USA.
³ Yale Center for Clinical Investigation, New Haven, CT 06511, USA.
⁴ VA Connecticut Healthcare System, West Haven, CT, USA.
⁵ Yale Cardiovascular Research Center, Section of Cardiovascular Medicine, New Haven, CT 06511, USA.

No abstract available

MeSH terms

COVID-19*
Humans
SARS-CoV-2*

Supplementary concepts

SARS-CoV-2 variants

Grants and funding

UL1 TR001863/TR/NCATS NIH HHS/United States